Company attributes
Industry
B2X
Founder
Pitchbook URL
Legal Name
Cellectis S.A.
Legal classification
Date Incorporated
December 1, 1999
Number of Employees (Ranges)
51 – 200
Phone Number
+33181691600
Full Address
8 RUE DE LA CROIX JARRY 75013, PARIS, ILE-DE-FRANCEFrance
CIK Number
Investors
Founded Date
1999
0Total Funding Amount (USD)
185,049,023
Latest Funding Round Date
April 2018
Stock Symbol
CLLS
Exchange
Latest Funding Type
Patents Assigned (Count)
64
Technologies Used
Country
Headquarters
Other attributes
Company Operating Status
Active
Ticker Symbol
CLLS
Wikidata ID
Cellectis is a clinical-stage biopharmaceutical company that is developing cancer immunotherapies and genome-edited chimeric antigen receptor T-cell technologies for curing cancer.
Timeline
No Timeline data yet.
